Biomarker Study of Acamprosate in Schizophrenia

Clinical trial NCT00688324 · COMPLETED

Trial details

NCT number: NCT00688324
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2008-06-01
Primary completion: 2012-02-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.